Back
4D Molecular Therapeutics Vs. Karyopharm Therapeutics Industry Stock Comparison
Sell
44
FDMT
4D Molecular Therapeutics
Last Price:
25.59
Seasonality Move:
-0.46%
Buy
58
KPTI
Karyopharm Therapeutics
Last Price:
1.13
Seasonality Move:
-4.13%
Sell
44
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy, Sell or Hold?
- The current 4D Molecular Therapeutics [FDMT] share price is $25.75. The Score for FDMT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Karyopharm Therapeutics (KPTI)
is a Buy
Is Karyopharm Therapeutics a Buy, Sell or Hold?
- The current Karyopharm Therapeutics [KPTI] share price is $1.09. The Score for KPTI is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- KPTI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FDMT Stock Price Chart
What is 4D Molecular Therapeutics's stock price today?
-
The 4D Molecular Therapeutics share price today is $25.75
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.
KPTI Stock Price Chart
What is Karyopharm Therapeutics's stock price today?
-
The Karyopharm Therapeutics share price today is $1.09
The current trend is relatively stagnant and KPTI is experiencing selling pressure, which indicates risk of future bearish movement.
FDMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 46.92 | Sell |
| Chaikin Money Flow: | -352330 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.49 - 26.73) | Buy |
| Bollinger Bands (100): | (20.6 - 30.16) | Buy |
KPTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 45.29 | Sell |
| Chaikin Money Flow: | -1216685 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.04 - 1.22) | Sell |
| Bollinger Bands (100): | (0.9 - 1.4) | Sell |
FDMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.11 | Sell |
| 20-day SMA: | 25.32 | Buy |
| 50-day SMA: | 27.99 | Sell |
| 200-day SMA: | 19.63 | Buy |
| 8-day EMA: | 25.78 | Sell |
| 20-day EMA: | 25.98 | Sell |
| 50-day EMA: | 26.38 | Sell |
| 200-day EMA: | 22 | Buy |
KPTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.1 | Sell |
| 20-day SMA: | 1.12 | Sell |
| 50-day SMA: | 1.27 | Sell |
| 200-day SMA: | 1.15 | Sell |
| 8-day EMA: | 1.09 | Sell |
| 20-day EMA: | 1.13 | Sell |
| 50-day EMA: | 1.18 | Sell |
| 200-day EMA: | 1.44 | Sell |
4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.29 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.20 per share.
Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.02 per share, and an increase next year of $0.34 per share.
4D Molecular Therapeutics Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Karyopharm Therapeutics Technical Analysis
| May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||